GlobalNews411

Comprehensive reporting, aggregated for speed.

allentown

Doctors stunned after promising Novartis heart drug fails major study

The drug lowered lipoprotein(a), a genetic heart-risk factor, but did not cut heart attacks, strokes or cardiovascular deaths in a major trial.

Published Sep 9, 2026, 6:00 AM EDT | LehighValleyLive

For years, heart doctors believed they might finally have a new way to prevent heart attacks and strokes in millions of people.